Company Overview
About Delineate
Delineate is a United States-based AI clinical trial design and biomedical data extraction company — providing pharmaceutical companies, academic research teams, and contract research organizations (CROs) with AI-powered systematic review automation that accelerates the data extraction and evidence synthesis workflows critical for designing better, faster clinical trials in the $10 billion clinical trial design and data services market. Partnered with two top-10 global pharmaceutical companies, Delineate has performed some of the largest systematic-review studies ever conducted in drug development, delivering 15x more processed studies than industry standard timelines and reducing certain study completion times from months to weeks through AI models that extract and analyze data from biopharma research papers, patents, and regulatory documents at scale.
Business Model & Competitive Advantage
Delineate's AI data extraction platform combines custom large language models with computer vision models trained specifically for biomedical literature: the clinical trial design process requires synthesizing evidence from hundreds to thousands of existing clinical studies to understand what treatment arms, dosing regimens, patient populations, and endpoints have already been tested — a systematic review process that traditionally requires teams of PhD-level researchers spending months manually extracting data tables, adverse event rates, efficacy outcomes, and patient criteria from papers. Critically, much of this data is "trapped" in figures and plots (bar charts of efficacy results, Kaplan-Meier survival curves, dose-response graphs) rather than in machine-readable tables — Delineate's computer vision models extract quantitative data from these visual formats with the accuracy required for clinical evidence synthesis. The rigorous quality control processes (automated consistency checks, uncertain extraction flagging for human review) address the clinical-grade accuracy requirements that pharmaceutical companies apply to evidence used for regulatory submissions.
Competitive Landscape 2025–2026
In 2025, Delineate competes in the AI clinical trial design, systematic review automation, and biopharma data extraction market with Sciome (computational toxicology and systematic review, NIH-contracted), Elsevier's Reaxys (scientific data extraction, RELX group), and Scite (AI citation analysis for scientific literature, $7M raised) for pharmaceutical company clinical evidence synthesis and trial design support. The systematic review and meta-analysis market has been one of the highest-value AI application areas in pharmaceutical R&D — the evidence synthesis step that informs trial design decisions (what comparator to use, what endpoint is most sensitive, what dose range to test) has historically been the most labor-intensive and time-consuming pre-clinical research activity. Top-10 pharma partnerships validate Delineate's clinical-grade accuracy for the high-stakes drug development workflows where errors in evidence synthesis could lead to suboptimal trial designs and significant capital waste. The 2025 strategy focuses on expanding the pharmaceutical company partnerships for late-phase trial design support, building the regulatory evidence package automation for NDA and BLA submissions, and growing the platform into real-world evidence (RWE) data extraction from electronic health records.
Company Timeline
Major milestones in Delineate's journey
Leadership Team
Meet the leaders behind Delineate
Emily Nieves
Jawad Iqbal
Open Positions
Reddit Discussions
Key Differentiators
Emerging Innovator
Delineate is an emerging player bringing innovative solutions to the Healthcare Tech market.
Frequently Asked Questions
Not So Random Others
YouShift
YouShift is a United States-based AI healthcare workforce management platform — building the operating system for healthcare staffing starting with AI-powered scheduling agents that replace the comple
Hermes Robotics
Hermes Robotics is an autonomous mobile robot (AMR) and warehouse automation company developing robots and software for logistics and fulfillment operations in warehouses, distribution centers, and ma
Brisk
Brisk is a functional beverage brand offering ready-to-drink iced tea and juice drinks, jointly owned by PepsiCo and Unilever under the Lipton brand partnership. Launched in the 1990s, Brisk positione
Bucket Robotics
Bucket Robotics is an autonomous mobile robot (AMR) company that designs modular, rapidly deployable robots for warehouse automation and industrial material handling. Unlike traditional warehouse auto
Altria
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and s
Dusty Robotics
Dusty Robotics is a Mountain View, California-based construction robotics company — backed with $69.5 million in total funding from Root Ventures, Scale Venture Partners, Canaan Partners, GRIDS Capita
Compare Delineate with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Delineate? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Delineate Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Delineate vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →